Skip to main content

4 Result(s)

within Chueh-Chuan Yen Remove this filter

and
Your search also matched 14 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response—a retrospective study

Include preview-only content

  1. Article

    Open Access

    Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has significantly improved the survival of patients with GISTs. We aimed to evalu...

    Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, Chin-Fu Hsiao, Chung-Hsin Tsai… in BMC Cancer (2024)

    Download PDF (1790 KB) View Article

  2. Article

    Open Access

    Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?

    Adjuvant FOLFOX (5-fluorouracil and oxaliplatin) chemotherapy benefits stage III colon cancer patients. However, it still results in side effects and increased cost. Reducing cycles had been thought to decreas...

    Yi-Jian Tsai, Jen-Kou Lin, Wei-Shone Chen, Jeng-Kai Jiang, Hao-Wei Teng… in SpringerPlus (2016)

    Download PDF (986 KB) View Article

  3. Article

    Open Access

    Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy

    The impact of KRAS signaling on cancerous inhibitor of protein phosphatase 2A (CIP2A) expression has not yet been explored. We investigated the impact of KRAS on CIP2A expression in colorectal cancer patients ...

    Kuen-Feng Chen, Chueh-Chuan Yen, Jen-Kou Lin, Wei-Shone Chen, Shung-Haur Yang… in BMC Cancer (2015)

    Download PDF (1227 KB) View Article

  4. Article

    Open Access

    Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study

    Carcinoma of unknown primary site (CUP) has a poor prognosis and the prognostic factors in these patients are not well established. Furthermore, there are no selection criteria for patients who should benefit ...

    Kuo-Wei Chen, Chia-Jen Liu, Hsueh-Ju Lu, Cheng-Hwai Tzeng… in BMC Research Notes (2012)

    Download PDF (937 KB) View Article